Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Radiation × Other solid neoplasm × Clear all

Phase

Phase 1 5 Phase 2 2 Phase NA 1 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 22 Genitourinary 19 Lymphoid 17 Sarcoma 12 CNS 12 Other hematologic neoplasm 11 Gynecologic 9 Thoracic 8 Head & Neck 6 Breast 6 Tumor-Agnostic 2 Myeloid 2 Dermatologic 2 Other solid neoplasm 1

Conditions

Interventions

Carboplatin 9 Cisplatin 7 Pemetrexed 6 Nivolumab 5 Vincristine 4 Topotecan 3 Ipilimumab 3 Injections 3 Etoposide 3 Doxorubicin 3 Talc 2 Specimen Handling 2 Radiotherapy 2 Paclitaxel 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2 Filgrastim 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 ranpirnase 1 raltitrexed 1 pertuzumab 1 pembrolizumab 1 iniparib 1 durvalumab 1 dostarlimab 1 crofelemer 1 atezolizumab 1 Vorinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01604005 2018-01-29

PIT

The Christie NHS Foundation Trust

Phase 3 Terminated

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡